Results of Expert Meetings
The Data and Safety Monitoring Committee: Some final thoughts,☆☆

https://doi.org/10.1067/mhj.2001.113837Get rights and content

References (3)

There are more references available in the full text version of this article.

Cited by (7)

  • Sodium-Hydrogen Exchange Inhibition by Cariporide to Reduce the Risk of Ischemic Cardiac Events in Patients Undergoing Coronary Artery Bypass Grafting: Results of the EXPEDITION Study

    2008, Annals of Thoracic Surgery
    Citation Excerpt :

    The planned sample size of 7,000 assumed a 12% primary event rate at day 5 for the placebo group and a 20% relative risk reduction in the cariporide treatment arm, a two-sided type 1 error rate of 5%, and power approximately 90%. The protocol specified rules for the conduct of the interim analyses by the Data Safety Management Board to allow stopping the study early for overwhelming evidence of efficacy or for futility [10, 11]. Rules for early termination for efficacy required a nominal significance level of 0.00001 with demonstration of reduction in risk for both components of the primary endpoint (death or nonfatal MI by day 5).

  • Data monitoring and safety committees and their operations

    2003, Obstetrical and Gynecological Survey
View all citing articles on Scopus

Reprint requests: David L. DeMets, PhD, Department of Statistics and Biostatistics, University of Wisconsin, 600 Highland Ave, K6/446, Madison, WI 53792-4675. E-mail: [email protected]

☆☆

Am Heart J 2001;141:548-9.

View full text